{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:55Z","timestamp":1792782475364,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23AA2003"],"award-info":[{"award-number":["23AA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The University of Tokyo","id":[{"id":"https:\/\/ror.org\/057zh3y96","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00198-026-08023-4","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:30:22Z","timestamp":1776677422000},"page":"1855-1866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of a national reimbursement add-on policy on refracture risk and secondary fracture prevention after hip fracture in Japan: a population-based interrupted time series analysis"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-5604","authenticated-orcid":false,"given":"Masaki","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatoshi","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"8023_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10428","volume":"5","author":"E Takusari","year":"2021","unstructured":"Takusari E, Sakata K, Hashimoto T, Fukushima Y, Nakamura T, Orimo H (2021) Trends in hip fracture incidence in Japan: estimates based on nationwide hip fracture surveys from 1992 to 2017. JBMR Plus 5:e10428","journal-title":"JBMR Plus"},{"key":"8023_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01607-3","volume":"20","author":"M Hatano","year":"2025","unstructured":"Hatano M, Yasunaga H, Ishikura H, Tanaka T, Aso S, Tanaka S (2025) Temporal trends in acute care costs of hip fracture treatment from 2011 to 2021 in Japan. Arch Osteoporos 20:124","journal-title":"Arch Osteoporos"},{"key":"8023_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00198-019-04852-8","volume":"30","author":"J Banefelt","year":"2019","unstructured":"Banefelt J, \u00c5kesson KE, Sp\u00e5ng\u00e9us A, Ljunggren O, Karlsson L, Str\u00f6m O, Orts\u00e4ter G, Libanati C, Toth E (2019) Risk of imminent fracture following a previous fracture in a Swedish database study. Osteoporos Int 30:601\u2013609","journal-title":"Osteoporos Int"},{"key":"8023_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04051-9","volume":"22","author":"JD Adachi","year":"2021","unstructured":"Adachi JD, Brown JP, Schemitsch E et al (2021) Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada. BMC Musculoskelet Disord 22:224","journal-title":"BMC Musculoskelet Disord"},{"key":"8023_CR5","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES (2022) The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 33:2049\u20132102","journal-title":"Osteoporos Int"},{"key":"8023_CR6","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","volume":"32","author":"N Li","year":"2021","unstructured":"Li N, Hiligsmann M, Boonen A, van Oostwaard MM, de Bot R, Wyers CE, Bours SPG, van den Bergh JP (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32:1517\u20131530","journal-title":"Osteoporos Int"},{"key":"8023_CR7","unstructured":"Physicians RCo Fracture Liaison Service Database (FLS-DB) annual report 2025. https:\/\/www.rcp.ac.uk\/media\/hlmh3g5g\/fls-db-2025-annual-report-2.pdf. Accessed 6 Jan 2026"},{"key":"8023_CR8","doi-asserted-by":"publisher","first-page":"e180826","DOI":"10.1001\/jamanetworkopen.2018.0826","volume":"1","author":"RJ Desai","year":"2018","unstructured":"Desai RJ, Mahesri M, Abdia Y et al (2018) Association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis. JAMA Netw Open 1:e180826","journal-title":"JAMA Netw Open"},{"key":"8023_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00198-020-05557-z","volume":"32","author":"E McCloskey","year":"2021","unstructured":"McCloskey E, Rathi J, Heijmans S et al (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32:251\u2013259","journal-title":"Osteoporos Int"},{"key":"8023_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00198-024-07269-0","volume":"36","author":"G Gondo","year":"2025","unstructured":"Gondo G, Shin JH, Kunisawa S, Imanaka Y (2025) Impact of the guidance on fracture liaison services and the introduction of a new fee for secondary fracture prevention in Japan: implementation of secondary fracture prevention during hospitalization for fragility fractures. Osteoporos Int 36:235\u2013244","journal-title":"Osteoporos Int"},{"key":"8023_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2024.111452","volume":"55","author":"N Yamamoto","year":"2024","unstructured":"Yamamoto N, Sawaguchi T, Matsushita T et al (2024) Fragility fracture network-Japan: the challenge of establishment of a national hip fracture database and successful achievement of nationwide health system change for hip fracture care in Japan. Injury 55:111452","journal-title":"Injury"},{"key":"8023_CR12","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s00198-025-07721-9","volume":"36","author":"Y Takegami","year":"2025","unstructured":"Takegami Y, Imaizumi T, Sato K, Osawa Y, Funahashi H, Imagama S (2025) Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis. Osteoporos Int 36:2509\u20132518","journal-title":"Osteoporos Int"},{"key":"8023_CR13","first-page":"190","volume":"5","author":"A Okada","year":"2022","unstructured":"Okada A, Yasunaga H (2022) Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering young, middle-aged, and elderly people. JMA J 5:190\u2013198","journal-title":"JMA J"},{"key":"8023_CR14","unstructured":"Hagino H (2015) [On \u201c2015 Guidelines for Prevention and Treatment of Osteoporosis\u201d. Overview and the aim of the treatment of osteoporosis]. Clin Calcium 25(9):1273\u20131277. (Japanese)"},{"key":"8023_CR15","unstructured":"Japan FFN (2020). https:\/\/ffn.or.jp\/archives\/news_top\/fls\u30af\u30ea\u30cb\u30ab\u30eb\u30b9\u30bf\u30f3\u30c0\u30fc\u30c9\u304a\u3088\u3073\u5b9f\u8df5\u30de\u30cb\u30e5\u30a2\u30eb\/.\u00a0 Accessed 17 Nov 2025"},{"key":"8023_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00198-020-05377-1","volume":"31","author":"MK Javaid","year":"2020","unstructured":"Javaid MK, Sami A, Lems W et al (2020) A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF capture the fracture working group, national osteoporosis foundation and fragility fracture network. Osteoporos Int 31:1193\u20131204","journal-title":"Osteoporos Int"},{"key":"8023_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-025-01588-3","volume":"20","author":"CL Gregson","year":"2025","unstructured":"Gregson CL, Armstrong DJ, Avgerinou C et al (2025) The 2024 UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 20:119","journal-title":"Arch Osteoporos"},{"key":"8023_CR18","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.ard.2025.06.2124","volume":"84","author":"M Hatano","year":"2025","unstructured":"Hatano M, Sasabuchi Y, Okada A et al (2025) Osteoarthritis risk associated with romosozumab compared with teriparatide in individuals with osteoporosis: a target trial emulation study. Ann Rheum Dis 84:1938\u20131947","journal-title":"Ann Rheum Dis"},{"key":"8023_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"8023_CR20","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139","journal-title":"Med Care"},{"key":"8023_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10654-024-01191-9","volume":"40","author":"JA Hanley","year":"2025","unstructured":"Hanley JA (2025) Risks and rates, and the mathematical link between them. Eur J Epidemiol 40:1\u201315","journal-title":"Eur J Epidemiol"},{"key":"8023_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","volume":"111","author":"CH Wu","year":"2018","unstructured":"Wu CH, Tu ST, Chang YF, Chan DC, Chien JT, Lin CH, Singh S, Dasari M, Chen JF, Tsai KS (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92\u2013100","journal-title":"Bone"},{"key":"8023_CR23","unstructured":"England N (2025) 2025\/26 NHS Payment scheme: annex C \u2013 guidance on best practice tariffs. https:\/\/www.england.nhs.uk\/long-read\/25-26-nhsps-annex-c-guidance-on-best-practice-tariffs\/ Accessed 14 Jan 2026"},{"key":"8023_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1302\/0301-620X.101B8.BJJ-2019-0173.R1","volume":"101-b","author":"D Metcalfe","year":"2019","unstructured":"Metcalfe D, Zogg CK, Judge A, Perry DC, Gabbe B, Willett K, Costa ML (2019) Pay for performance and hip fracture outcomes: an interrupted time series and difference-in-differences analysis in England and Scotland. Bone Joint J 101-b:1015\u20131023","journal-title":"Bone Joint J"},{"key":"8023_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-014190","volume":"7","author":"B Oakley","year":"2017","unstructured":"Oakley B, Nightingale J, Moran CG, Moppett IK (2017) Does achieving the best practice tariff improve outcomes in hip fracture patients? An observational cohort study. BMJ Open 7:e014190","journal-title":"BMJ Open"},{"key":"8023_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamainternmed.2021.6745","volume":"182","author":"WJ Deardorff","year":"2022","unstructured":"Deardorff WJ, Cenzer I, Nguyen B, Lee SJ (2022) Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: a meta-analysis of randomized clinical trials. JAMA Intern Med 182:33\u201341","journal-title":"JAMA Intern Med"},{"key":"8023_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-024-01410-6","volume":"19","author":"L Bullock","year":"2024","unstructured":"Bullock L, Manning F, Hawarden A et al (2024) Exploring practice and perspectives on shared decision-making about osteoporosis medicines in fracture liaison services: the iFraP development qualitative study. Arch Osteoporos 19:50","journal-title":"Arch Osteoporos"},{"key":"8023_CR28","doi-asserted-by":"publisher","unstructured":"Bullock L, Tyler N, Fleming J, Clark EM, Thomas S, Gidlow C, Iglesias-Urrutia CP, Horne R, Bentley I, Hawarden A, Peel N, Gregson CL, Ralston SH, Protheroe J, Lefroy J, Ryan S, O'Neill TW, Mallen C, Jinks C, Paskins Z (2026) The Michael Mason prize: development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicine. Rheumatology (Oxford) 65(1). https:\/\/doi.org\/10.1093\/rheumatology\/keaf413","DOI":"10.1093\/rheumatology\/keaf413"},{"key":"8023_CR29","doi-asserted-by":"publisher","unstructured":"Singh S, van den Berg P, Fergusson K, Martins Pinto J, Koerner-Bungey T, Chan DD, Boonnasa W, Javaid MK, Speerin R (2023) Preventing the next fragility fracture: a cross-sectional survey of secondary fragility fracture prevention services worldwide. BMJ Open Qual 12(Suppl 2). https:\/\/doi.org\/10.1136\/bmjoq-2023-002290","DOI":"10.1136\/bmjoq-2023-002290"},{"key":"8023_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13012-015-0243-z","volume":"10","author":"S Drew","year":"2015","unstructured":"Drew S, Judge A, May C, Farmer A, Cooper C, Javaid MK, Gooberman-Hill R (2015) Implementation of secondary fracture prevention services after hip fracture: a qualitative study using extended normalization process theory. Implement Sci 10:57","journal-title":"Implement Sci"},{"key":"8023_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.afos.2019.09.003","volume":"5","author":"H Hagino","year":"2019","unstructured":"Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65\u201368","journal-title":"Osteoporos Sarcopenia"},{"key":"8023_CR32","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00198-023-06748-0","volume":"34","author":"MJ Bennett","year":"2023","unstructured":"Bennett MJ, Center JR, Perry L (2023) Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study. Osteoporos Int 34:1249\u20131262","journal-title":"Osteoporos Int"},{"key":"8023_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jbmr.3877","volume":"35","author":"RB Conley","year":"2020","unstructured":"Conley RB, Adib G, Adler RA et al (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Bone Miner Res 35:36\u201352","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08023-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08023-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-08023-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:00Z","timestamp":1792270920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-08023-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8023"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-08023-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Guarantor Masaki Hatano accepts full responsibility for the work and conduct of the study, has full access to the data, and controls the decision to publish it.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the University of Tokyo [approval number: 2021010NI (23 April 2021)]. The requirement for informed consent was waived because all the data were de-identified.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"H. Yasunaga reports receiving an institutional grant from the Ministry of Health, Labor and Welfare, Japan (23AA2003). Tanaka has a collaborative research agreement with Amgen Inc. for a project involving the development and validation of hip and vertebral fractures using a claims database. T. Saito received lecture fees, outside the submitted work, from Kyowa Kirin Co., Ltd. S. Tanaka received lecture fees, outside the submitted work, from Asahi Kasei Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Teijin Healthcare Limited, Amgen K.K., and Daiichi Sankyo Co., Ltd. Masaki Hatano, Yuya Kimura, and Hisatoshi Ishikura declare no conflicts of interest.","order":4,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author attests that all listed authors meet the authorship criteria, and that no others meeting the criteria have been omitted.","order":5,"name":"Ethics","label":"Authorship confirmation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Large language models (LLMs) were used solely for spelling and grammar checks. LLMs were not used for data analysis, data interpretation, or drafting scientific conclusions.","order":6,"name":"Ethics","label":"AI-assisted technology disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}]}}